TRCT
ADPT

Tower Research Capital (TRC)’s Adeptus Health Inc ADPT Stock Holding History

Tower Research Capital (TRC)’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,760
Closed -$21K – 4540
2016
Q4 		$21K Buy
+2,760
New +$50.8K ﹤0.01% 2119
2016
Q2 		– Sell
-9
Closed – – 5408
2016
Q1 		$0 Buy
+9
New +$466 ﹤0.01% 5534
2015
Q4 		– Sell
-325
Closed -$26K – 5515
2015
Q3 		$26K Buy
+325
New +$33.5K ﹤0.01% 1534
2015
Q2 		– Sell
-66
Closed -$3K – 5452
2015
Q1 		$3K Sell
66
-77
-54% -$3.05K ﹤0.01% 3660
2014
Q4 		$6K Sell
143
-3,552
-96% -$112K ﹤0.01% 2646
2014
Q3 		$92K Buy
+3,695
New +$96.5K 0.01% 1048

Other funds holding ADPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SFM
Sterling Fund Management Chicago, Illinois $1.82M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Tower Research Capital (TRC)'s ADPT Position: Q1 2017 in Review

Tower Research Capital (TRC) sold out of Adeptus Health Inc (ADPT) in Q1 2017, closing a stake of 2,760 shares — an estimated $21K sold.

Tower Research Capital (TRC) first reported a position in ADPT in Q3 2014 and held it in 6 quarters. The position peaked at $92K in Q3 2014. 85 funds tracked by Wall St. Rank hold ADPT as of Q1 2017.

  • Tower Research Capital (TRC) reported no remaining Adeptus Health Inc position as of Q1 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2,760 Adeptus Health Inc shares in Q1 2017, an estimated $21K.
  • Tower Research Capital (TRC) first reported a position in Adeptus Health Inc in Q3 2014 and held it in 6 quarters.
  • Tower Research Capital (TRC)'s Adeptus Health Inc position peaked at $92K in Q3 2014.
  • 85 funds tracked by Wall St. Rank held Adeptus Health Inc as of Q1 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2017, filed 19 May 2017.